DNA methylation plays an important role during embryonic development under normal conditions and an abnormal pattern of DNA methylation can lead to deleterious effects such as cancer. Hence it is important to estimate the level of methylation both for diagnosis and for research purposes. Luminometric DNA methylation assay (LUMA) is an efficient and sensitive method to estimate CpG methylation. It is based on methylation sensitive HpaII and methylation insensitive MspI restriction enzymes and EcoRI which serves as an internal control.
Summary:
DNA methylation plays an important role during embryonic development under normal conditions and an abnormal pattern of DNA methylation can lead to deleterious effects such as cancer. Hence it is important to estimate the level of methylation both for diagnosis and for research purposes. Luminometric DNA methylation assay (LUMA) is an efficient and sensitive method to estimate CpG methylation. It is based on methylation sensitive HpaII and methylation insensitive MspI restriction enzymes and EcoRI which serves as an internal control.
In the present work DNA sample, from human peripheral blood and a human hepatoma cell line (Hep3B) were used to estimate the level of methylation. The Hep3B cells were treated with Trichostatin A (TSA), a histone deacetylase inhibitor. These studies demonstrated that TSA treatment resulted in a dose dependent decrease in DNA methylation. These LUMA results were corroborated by another technique called Nearest Neighbour Analysis (NNA), in which the methylated nucleotides can be identified. It involves FokI restriction digestion of DNA, followed by radiolabeling with α 32 P dGTP followed by DNA digestion to deoxyribonucleotide 3' monophosphates using a combination of micrococcal nuclease and calf phosphodiesterase. The radiolabeled 5'α phosphates of the 32 P dGTP then appear as the 3' phosphate of the nucleotides which are immediately 5' in the DNA (its nearest neighbour). The results showed that treatment of Hep3B cells with increasing concentrations of TSA led to a decrease in methylation level within the range tested from 0-800nM.
To further develop the LUMA technique, multiple enzymes, apart from HpaII and MspI were used to show the sensitivity of these enzymes for DNA methylation in the cancerous blood samples. It is obvious that these techniques are highly sensitive and highly reproducible to estimate both genomic and global DNA methylation at minute levels and these techniques also allow the use of a broad spectrum of enzymes, sensitive to DNA methylation.
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Introduction:
DNA methylation is a process in which DNA under goes chemical modification that can be inherited without changing the DNA sequence. DNA methylation occurs on the 5 th carbon atom of cytosine thus creating 5-methylcytosine (m5C). This addition of a methyl group to the nucleotide(s) may lead to transcriptional silencing in vertebrates. The majority of 5-methylcytosines in mammalian DNA are present in CpG dinucleotides (Gruenbaum et al, 1981 , Plass 2002 . These modifications of DNA do not alter the primary DNA sequence code ( fig.1) . Fig.1 An illustration of DNA methylation (methyl cytosine mdCp) which involves addition of methyl group to the DNA sequence without sequence alteration.
However they are heritable through cell divisions and regulate gene expression (Plass. 2002) . The changes in genomic DNA methylation are recognised as important events for normal development as well as pathological conditions (Paulsen et al, 2001 ) such as cancer and imprinting disorders. During development, gene regulation by DNA methylation includes tissue specific gene regulation and also processes such as X-chromosome inactivation and genomic imprinting. Genomic imprinting can be defined as the differential epigenetic marking of the parental genomes of the organisms with respect to their parental origin and epigenetics refers to reversible heritable changes in gene regulation that does not alter the DNA sequence (Costello et al, 2001) imprinted genes are preferentially expressed 2 from only one of the parental copies. The most important epigenetic modification involved in imprinting in mammals is CpG methylation.
Imprinting is a process that involves control of a small proportion of genes in the genome. The expression of an imprinted allele is solely determined on the parent that contributes it. Beckwith-Wiedman's syndrome, a genetic disorder, associated with defects in abdominal walls and neonatal hypoglycaemia, and Praderwilli/Angelman syndrome, associated with severe developmental delay or mental retardation, severe speech impairment, gait ataxia or tremulousness of the limbs and a unique behaviour (Paulsen et al, 2001 ) are examples of these disorders. If the methylation patterns are not properly established or maintained this will lead to impairments such as mental retardations, immune deficiencies and sporadic or inherited cancers (Costello and Plass 2001) .
DNA methylation is an enzymatic modification performed by DNA methyltransferases. DNA methyltransferases, namely Dnmt1, Dnmt3a and Dnmt 3b, are crucial for transferring the methyl group to the DNA and the added methyl group does not alter the DNA sequence and DNA base pairing but the protruding methyl groups in the major groove affects DNA-protein interactions. Dnmt3a and Dnmt3b use unmethylated DNA as a substrate for methylation and Dnmt1 maintains the methylated DNA by copying DNA methylation patterns to the daughter strands during DNA replication. Proper maintenance of DNA methylation leads to successful transfer of the methylated DNA copy to the daughter cell.
DNA methylation and diseases:
The best known examples of the relationship between changes in DNA methylation and disease are found in cancer. This has been found both in tumors and in cultured cell lines, and includes genome-wide demethylation that affects repeated sequences as well as local hypermethylation (Hoopes et al, 1986) . Two other human disorders, the Rett syndrome, which is characterised as a neurological disorder, and X-linked alpha thalasemia, a mental retardation syndrome and craniofacial, genital, and developmental manifestations are prominent among the most severely affected individuals have been found to carry mutations in genes that are involved either in DNA methylation or in methylation mediated regulations (Hansen et al 1999; Gibbons et al 2000; Paulsen et al, 2001 ).
It has also been shown that DNA hypomethylation can lead to chromosomal instability in Dnmt1 knockout embryonic stem cells and in cells treated with the demethylating agent 5-aza-deoxycytidine. Such changes in genomic DNA methylation are considered to be important events. To analyze these changes, different methods have been developed to estimate the level of DNA methylation before the onset of any impairment in cellular activities (Pogribny et al, 1999; Balaghi et al, 1993; Xiong et al, 1997) .
In almost all types of human tumours hypermethylation of tumor suppressor genes has been found, DNA methyltransferases are responsible for suppression of tumour suppresser genes and hence, DNA methyltransferase inhibitors are promising agents in cancer therapy (Lyko et al, 2005) .
Methylation assays background:
Luminometric DNA methylation assay is a novel method to estimate genome-wide DNA methylation. The method is quantitative, highly reproducible and easy to use even at minute levels of DNA methylation in a minimum amount of DNA ranging from 200 to 500 ng. LUMA is based on digestion of DNA by HpaII and MspI, HpaII is methylation sensitive i.e unable to cut the methylated DNA sequence while MspI is insensitive i.e cuts the DNA sequence irrespective of its methylation status. Both HpaII and MspI recognise the CCGG sequence and EcoRI serves as an internal control in this method (Karimi et al, 2006) . HpaII and MspI produce GC over hangs whereas EcoRI produces AATT overhangs.
After restriction cleavage of DNA, each successful incorporation of a dNTP is accompanied by release of pyrophosphate (PPi) (Figure 2 ). In the second step, ATP sulfurylase (a synthetic form of ATP) quantitatively converts the PPi into ATP, in the presence of adenosine-5'phosphosulphate (APS). Luciferase and ATP catalyse conversion of luciferin to oxyluciferin, which generates visible light signal which is proportional to the amount of ATP. This light is detected by a CCD camera in the Pyrosequencing machine and generates peaks proportional to the number of dNTPs added to the DNA strand (Mostafa Ronaghi 2001). Based on the peak levels at respective sites the methylation level will be measured. Genomic DNA of the test samples is cleaved with two restriction enzymes HpaII+EcoRI or MspI+EcoRI the extent of cleavage is determined by a polymerase extension assay based on four-step Pyrosequencing reaction. Afetr each nucleotide incorporation inorganic phosphate (PPi) is released and convert it into ATP by ATP sulphrylase.Luciferin is coverted by luciferase and ATP to produce a proportional amount of visible light that is detected by a CCD camera the amount of light is directely proportional to number of nucleotides incorporated. The A and T peaks corresponding to step 1 and 3 reflects the EcoRI cleavages which should be equal. The C+G peaks in step 2 corresponds to cleavage of HpaII and MspI. The second C+G cleavage is an internal control and should be close to zero. Addition of right nucleotide to the cleaved site leads to release of PPi which will be converted in to light signal is the concept behind Pyrosequencing. (The figure was reproduced with permission from the copy right holder Karimi et al, 2006) . Nearest Neighbour Analysis (NNA) is a technique based on DNA digestion with FokI, a type II restriction enzyme from Flavobacterium okeanokoites. FokI enzyme recognises GGATGN 9-13 producing a staggered cut site. The digested DNA will be radiolabeled with α 32 P dGTP and digested with micrococcal nuclease and phosphodiesterase to obtain free, labelled nucleotides. Finally thin layer chromatography (TLC) was run to detect the methylation pattern of the nucleotides, based on the pattern of the nucleotides migrated on cellulose plates. The radiolabeled 5' α -phosphate of the [α-32 P] dNTP will appear as the 3' phosphate of the nucleotide that was immediately 5' in the DNA (its nearest neighbour) (figure 3) (Gruenbaum et al, 1981) . 
Aims:
Aim of the present work were to estimate the genomic DNA methylation at minute levels, analysis of effect of Trichostatin A, on DNA methylation and further improvement of luminometric DNA methylation assay.
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Results:
In order to analyse and estimate the level of DNA methylation, the highly reproducible and sensitive luminometric DNA methylation assay was used. LUMA had been standardised in this laboratory using fully methylated lambda DNA (Karimi et al, 2006 ). An inverse correlation between CpG methylation and HpaII activity over MspI activity had been observed when methylated DNA was mixed with unmethylated DNA in different proportions. According to standardisation (Karimi et al, 2006 ) the ration of HpaII activity over MspI actity were highest in unmethylated DNA (1.0) and lowest in methylated DNA (close to 0) and the ratios were calculated by dividing the ratios HpaII (C+G) activity over E.CoRI (A) activity by the ratio of MspI (C+G) activity over E.CoRI(A) activity, obtaining a normalized value of HpaII/MspI activity, which was the higher the ratio the lower the methylation level. The HpaII activity over EcoRI activity ratio is reflecting the relative activity of HpaII digestion using EcoRI as an internalcontrol.
HpaII activity over MspI activity concentration of TSA led to a decrease in methylation level and a maximum decrease in methylation was seen at 800nM TSA that gave 0.9 ratio. Beyond 800nM concentration of TSA the Hp3B cells were tested for their methylationlevel but apoptosis was observed. So decreasing HpaIIactivity over EcoRI activity ratios indicated the loss of methylation when the concentration of TSA was increased. Figure 5 shows the position of labelled nucleotides after running thin layer chromatography (refer to figure 3 for standard positions of the nucleotides on thin layer chromatograms). The arrow in each chromatogram indicates the position of methylcytocine (mdCp). The relative amounts of methyl-cytosine from TSA treated Hep3B cells were estimated using Image Gage software, in this system the phosphoimagers that were exposed to chromatographic plates were put in the Image Gage operator and the exposed nucleotides intensities were measured. The obtained values were plotted in figure 6. In the following figure, DNA methylation at 800nM the value obtained was 74. Thus both the LUMA and the NNA assays showed similar patterns of DNA methylation, i.e dose dependent decrease in methylation up on TSA treatment. Now another aim of the present work was to further develop the LUMA method, by using multiple methylation sensitive restriction enzymes, apart from HpaII and MspI. To this end I employed NotI, BssHII, Eco52I, Hin6I, and Hpychy IV in addition to HpaII. Figure 7 shows results from four different blood samples using LUMA with, the different enzymes, on xaxis different enzymes used to detect methylation levels in the peripheral blood samples and their level of methylation on y-axis. The figure shows that LUMA can be used to estimate the level of methylation in a given DNA sample using methylation sensitive enzymes other than HpaII and MspI. The HpaII/EcoRI restriction results showed hypermethylation in DNA from blood samples-1 and 2, while in samples 3 and 4 hypomethylation was observed. The MspI restriction peak levels are high as it cuts the DNA sequence irrespective of methylation. NotI, BssHII and Eco52I are CpG methylation sensitive enzymes recognising other CpG sites besides CCGG. These enzymes also indicated hypermethylation of the samples. Hin6I alone showed similar methylation level as HpaII, as did HypCH4IV, alone or in combination with HpaII, Hin6I and HypCH4IV gave ratios of similar methylation as HpaII, starting from higher methylation in blood sample-1 than blood sample-4.
Discussion:
In the present work I used different sources of DNA samples for my study of detection of DNA methylation at minute levels. The data from the Luminometric DNA methylation assay and Nearest Neighbour Analysis show the efficiency of the methods, methylation specific sensitivity of the enzymes and importance of TSA as a cancer therapy agent. Even though it has been known for some time that methylcytosine is the only methylated base in eukaryotes, little was known about the sequence specificity of this modification. But important fact has emerged from the base analysis is that more than 90% methyl cytosine residues are found in CpG sequence (Sinsheimer, 1955) .
Abnormal methylation pattern have often been found in various types of cancer, thus in the present DNA methylation studies I used various cancer DNA samples along with hepatic cell lines (Hep3B) treated with Trichostatin A, which is a histone deacetylase inhibitor (HDAC i). Some group of studies have already shown that there is correlation exist between DNA-methylation and histone deacetylation (Christoph Plass, 2002) . Histone deacetylation results in chromatin condensation, which further leads to inaccessibility by transcription factors to DNA. The restriction enzymes HpaII and MspI have been to assay methylation at the sequence CCGG in eukaryotic DNA (Waalwijk et al, 1978) .
The data from LUMA analysis (figure 4) show the effect of TSA treatment in Hep3B cells and it can be seen from the results that there was dose dependent decrease in methylation level. To further validate these LUMA results, I employed another technique called Nearest Neighbour Analysis that involves DNA digestion by FokI restriction enzyme, radiolabeling, and further digestion with micrococcal nuclease and to digest the labelled DNA to free nucleotides so that methyl cytosine can be observed on thin layer chromatography.
Digestion of labelled DNA to mononucleotides and running the samples on chromatography, one can determine what percentage that the site is methylated (Cedar et al, 1979) .The technique of labelling cut sites by filling-in reactions, described in the present wok is a modification of the nick-labeling nearst neighbour analysis technique. The original technique of using DNase I to nick the DNA and polymerisation with DNA polymerase I that have yielded less reproducible results than fill-in method using Klenow DNA polymerase (Gruenbaum, et al, 1981) .
Based on observations from both of the methods it can be concluded that these techniques are efficient to study DNA methylation at minute levels and suggest that TSA can be used as one of the future cancer therapy drug. One of the aims of the present work was also to further develop the LUMA technique by using multiple, methylation sensitive enzymes and it was suggested that LUMA with multiple enzymes may be used to show both CpG specific methylation as well as non CpG methylation. It would be interesting to continue this work with more methylation sensitive enzymes.
Materials and Methods:
Cells and cell cultures:
Hep3B cells were cultured in Dulbecco modified eagle medium (DMEM) GIBCO-BRL with L-glutamine, 1000 mg/l D-glucose, containing sodium pyruvate. The medium was supplemented with 10% (v/v) fetal bovine serum (FBS) from GIBCO-BRL, 0.1% (v/v) streptomycin (100 μg/ml) penicillin (100 U/ml) from GIBCO-BRL. The cells were grown in a humidified 5% CO 2 incubator at 37
• C.
Biological samples and enzymes
For luminometric DNA methylation assay (LUMA) biological samples, human peripheral blood and TSA treated Hep3B cells were used. The restriction enzymes HpaII, EcoRI, MspI and FokI and NE4 buffer, 10X buffer were purchased from New England Biolab (MA, USA). Klenow DNA polymerase I, and micrococcal nuclease were purchased from USB (USA, Ohio) and phosphodiesterase was purchased from Worthington (USA, NJ). Trichostatin A was purchased from Sigma Aldrich (Stockholm, Sweden).
Kits and Chemicals:
DNA was extracted using Gen Elute mammalian genomic extraction kit purchased from Sigma Aldrich (Stockholm Sweden) and DNA concentration was estimated using a Nanodrop apparatus purchased from Saveen Werner (AB) (Sweden). The PSQ96™ MA Pyrosequencing system, from Biotage AB. dNTPs, enzymes and substrate kits for LUMA were purchased from Biotage AB and [α-32 P] dGTPs were purchased from Amersham Biosciences. Sephadex G50 columns purchased from Amersham Biosciences. Glass backed cellulose plates 20x20 cm were from MERCK (Darmstadt, Germany). Isobutyric acid, 30% ammonia solution saturated ammonium sulphate, 1 M acetic acid and isopropanol were purchased from MERCK (Darmstadt, Germany). Phosphoimager analysis was performed using Image Gauge software.
Luminometric DNA methylation assay:
LUMA was performed in 96 wells plate (from Biotage AB), and for each sample the reaction mixtures were divided as A and B. Reaction mixture A consisted of 2 μl of Tango buffer, (from Biotage AB) 13 μl of water 5 (U) of HpaII and 5U EcoRI and 5 μl of genomic DNA, reaction mixture B consisted of the same amounts of Tango buffer, water and EcoRI, but it contained MspI restriction enzyme instead of HpaII. In case of LUMA with multiple enzymes, each DNA sample was divided as A, B, C, D, E and F and consisted of all the components required for the reaction to occur as mentioned above, with only restriction enzymes differing per reaction.
Reaction mixture A contained HpaII+EcoRI, B contained MspI+EcoRI, C contained NotI, BssHII and Eco52I and EcoRI, D contained Hin6I+EcoRI, E contained HypCH4IV+EcoRI and F contained HpaII+EcoRI, Hin6I+EcoRI and HypCH4IV+EcoRI, (5U of each restriction enzyme). After addition of all the mentioned components to the wells, the plate was covered, so that the samples might not dry up during incubation at 37˚C for 4 hours. Followed by the digestion of samples, 20 µl of annealing buffer (purchased from Biotage AB for LUMA kit) was added to the each reaction mixture.
The Pyrosequencing cartridge wells were filled with 600 µl of enzyme-mix and 600 µl of substrate solutions were added to the wells and 50 µl dATP+50 µl of water, dTTP+50 µl of water, but for dCTP and dGTP, 50 µl dCTP+50 µl dGTP were mixed together to equilibrate the concentration of each dNTPs, were added in the cartridge wells according to the leaf-let provided in the kit and finally the pyrosequencing was performed.
Nearest Neighbour Analysis:
For nearest neighbour analysis 4 µg of DNA per sample was digested with 4U of FokI I restriction endonuclease for 4 hours at 37˚C, followed by precipitation using 10 µl of K-acetate, 3 M, 40 µl of dH 2 O and 250 µl of ethanol for total volume of 50 µl of FokI digested DNA. The DNA sample was precipitated at -20˚C over night and then centrifuged at 5000xg for 5-8 minutes. The supernatant was discarded and the DNA pellet was left to air dry for a few minutes and redissolved in 10 µl of water.
Radiolabeling:
To 10 µl of FokI digested DNA, 3 µl of [α-32 P] dGTP (from GE Life sciences), 1.5 µl 10x labelling buffer (HCl Tris 0.5 M and MgCl 2 0.1 M) and 0.5 µl of Klenow DNA polymerase (5U) was added. The sample was incubated at room temperature for 30 minutes to carry out the labelling process, after which labelling the reaction was terminated by adding 2 µl 0.2 M EDTA.
After labelling the DNA mix was transferred to Sephadex G50 column(s) and centrifuged at 5000g for 1 to 2 minutes. The flow through was collected and dried completely at 80˚C by putting the eppendorf tubes in a heating block. The DNA was further digested to individual nucleotides over night at 37˚C, using micrococcal nuclease 1 µl (0.2 units/reaction) and calf phosphodiesterase 2 µl in 5 µl of micrococcal nuclease buffer i.e Tris-HCl 10mM. Thin layer chromatography was performed, by applying about 1 to 1.5 μl sample (so that the application would give 500-1000 counts/s when a Geiger counter was held directly over it) was applied at the left side corner of a glass backed cellulose plate (From MERCK) at a distance of 1.5 cm from the bottom of the plate (see figure 3) . Thin layer chromatography was run in a glass tank in one direction vertically overnight in solution A (Solution A: 66 volumes isobutyric acid: 18 vol water: 3 vol 30% ammonia solution). The plate was taken out from solution A, dried up thoroughly for 4 hours and then the plate was placed in solution B for the second direction (Solution B: 80 volumes saturated ammonium sulphate: 18 vol 1 M acetic acid: 2 vol isopropanol). Then the plates were dried thoroughly, wrapped with polythene film and exposed in a phosphoimager for 6 to 8 hours and analysed.
Treatment of Hep3B cells with Trichostatin A:
TSA (Trichostatin A) was dissolved in dimethylsulfoxide (DMSO) at a concentration of 1 mM; aliquots were stored at -70˚ C. The cells were treated with TSA when they were subconfluent (60-70 %). The culture medium was removed and replaced with fresh culture medium supplemented with TSA, so that the final concentration of TSA in each aliquot would be 250, 500, 800 and 1200 nM respectively. As a negative control culture medium with an equal amount of DMSO was used. The cells were incubated for 10, 24 or 48 hours in a humidified 5% CO 2 incubator at 37˚C.
